Literature DB >> 573171

Determination of plasma erythropoietin levels: an early marker of tumor activity.

A Anagnostou, M S Chawla, L Pololi, W Fried.   

Abstract

A young female patient developed erythrocytosis during the third recurrence of a cerebellar hemangioblastoma. Elevated erythropoietin levels were found in the patient's plasma with normalization after resection of the tumor. High erythropoietin titers were also found in the tumor saline extract. A fourth recurrence of the tumor was heralded by a rising plasma erythropoietin level and gradual erythrocytosis despite the absence of change in the clinical picture or the brain scan. In this case, serial plasma erythropoietin determinations served as a useful early marker of the tumor activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 573171     DOI: 10.1002/1097-0142(197909)44:3<1014::aid-cncr2820440332>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Erythrocytosis caused by an erythropoietin-producing breast adenocarcinoma.

Authors:  R F Bohnen; M Banisadre; R N Gulbrandson; E D Zanjani
Journal:  West J Med       Date:  1990-04

2.  Polyglobulia in patients with hemangioblastomas is related to tumor size but not to serum erythropoietin.

Authors:  Marie T Krüger; Jan-Helge Klingler; Cordula Jilg; Christine Steiert; Stefan Zschiedrich; Vera Van Velthoven; Sven Gläsker
Journal:  Hered Cancer Clin Pract       Date:  2018-09-11       Impact factor: 2.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.